chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After I received the second shot on April 26th, I started feeling the side effects of chills, body aches and headache around 5 am the next morning which lasted for three days. A week later on May  6th, the area where I received my shot, I developed a rash on the area given the shot and the rash started there but spread all up and down my arms and my legs .I also was very fatigued and felt the need to go right to sleep at odd times of the day, not my usual sleeping pattern during the first week of May.  In addition, I started Physical Therapy for my neck and right arm at the end of March, two weeks before I got my first shot.  After I got the second shot, my right shoulder and neck started to throb in pain as I have been getting Physical Therapy for it for a few weeks already and set my recovery back. The issue is my right shoulder and neck started getting better prior to receiving the second Pfizer shot.  I called my doctor on May 10th because the rash moved from the shot area to both arms, legs, stomach and neck. I called my doctor and he prescribed Prednisone 25 mg, which I am taking now. I am on my third day of medication and the itching is slowly subsiding. My neck and right arm are getting better because I keep going to PT.
Patient got his third booster vaccine on 11/15/21, then presented to the emergency department the next day with chest pain and shortness of breath on exertion. The chest pain resolved with rest, and workup was negative, so he was discharged from the emergency department the same day with plans to follow up with his cardiologist. The patient does have history of chest pain with known bicuspid aortic valve thickening changes, and this was unlikely to be related to the vaccine.
maculopapular rash appearing on arms/ same rash but now involving arm, forearm, thighs, chest, abdomen and was very itchy; maculopapular rash appearing on arms/ same rash but now involving arm, forearm, thighs, chest, abdomen; This is a spontaneous report from a contactable physician (patient himself). A 42-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EIC4176, expiry date unknown), via an unspecified route of administration (left arm), on 11Jan2021 17:00, at single dose, for covid-19 immunization. Medical history included diabetes, hypertension and, migraine. Concomitant medication included metformin for diabetes; metoprolol for hypertension; and galcanezumab (EMGALITY) for migraine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EH9899, expiry date unknown), via an unspecified route of administration (left arm), on 21Dec2020 16:30, at single dose, for covid-19 immunization at the age of 42-years-old. The patient experienced maculopapular rash appearing on arms on 15Jan2021 14:00 which resolved/recovered on Jan2021 with Benadryl. On 16Jan2021, same rash but now involving arm, forearm, thighs, chest, abdomen and was very itchy - also resolved/recovered on Jan2021 with Benadryl. The patient had no other vaccine in four weeks, had no Covid prior vaccination, and had not been Covid-tested post vaccination.
didnt received second dose for 3 months; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and PRODUCT DOSE OMISSION ISSUE (didnt received second dose for 3 months) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (didnt received second dose for 3 months). At the time of the report, COVID-19 (COVID-19) and PRODUCT DOSE OMISSION ISSUE (didnt received second dose for 3 months) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient was treated with monoclonal antibodies on 24-02-2021.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Nonsignificant Follow up appended
FAST HEART RATE; This spontaneous report received from a patient concerned a 39 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included supraventricular tachycardia, nonsmoker, and non alcohol, and other pre-existing medical conditions included patient does not have any allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 23:45 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced fast heart rate. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fast heart rate on 09-APR-2021. This report was non-serious.
Tuesday 11/4/03 Received flu shot about 2:00 Pm. Thursday 11/6/03 7:00 PM started getting extreme rapid heart beat. After a couple hours, heart rate went lower but was still rapid. Friday 11/7/03 Heart rate was still rapid but felt like it dropped considerably. Felt a little warm so started taking Tylenol. That made me feel better so I felt like was beating it so I did not call doctor Friday. I was wrong; my throat started hurting Friday night. Saturday 11/8/03 throat was worse and could not stop coughing. Saturday morning, had temp of 100. Saturday night had temp of 101. Called clinic consulting nurse at 9:20 PM. She said if temp got over 101 to go to the emergency room at hospital. Did not go to emergency room and seen doctor first thing Monday morning 11/10/03. Monday 11/10/03 AM When I arrived at doctor's office, I had extreme rapid heart beat. At one point, they said my rate was 165. They sent me immediately by ambulance to Emergency room at hospital to get my heart rate down. They wouldn't even let my wife ride in ambulance with me. Took 3 hours to get heart rate down. They released me to go home. After a couple days my heart was back on track. Had slight temperatures on and off and it took four weeks for coughing to stop. I was coughing so hard and it felt like a lot of the time it was coming from center of my stomach so stomach hurt for several days. If you need further information from my medical records, I will approve for release to you. I was in good health on 11/4/03 when I received flu shot. Of course, we don't know if it was the flu shot that created the extreme rapid heart beat, sore throat, high temperature and so much coughing. I have never had this type of flu before with extreme rapid heart beat. Right now I have mixed feelings about ever taking another flu shot. I will be meeting with my doctor in August and discuss the upcoming flu season and flu shot. I would not want anyone to get this particular flu that I had. And as I said above, any medical information you want from my records I will approve for release. Nurse follow up on 05/25/04: "atrial fib, viral syndrome."
The patient had already received his second influenza vaccine for the 2020-2021 influenza season (2 doses for his first immunization to the flu) and he accidently received a third influenza vaccine dose. The first dose was 9/20 and second dose was 1 month later 10/20 to complete the course. He received a third dose 12/30 accidently
I have no energy and I wake up with a migraine every day. The pain in concentrated in my temples and behind my eyes. I do take Excedrin and Aspirin. Which helps very little. 01/2022 my fatigue became severe. I slept 18 hours a day. I did go to the doctor in 02/2022. They did do labs and they told me my Vitamin D levels are at zero. They have put me on medication to increase my Vitamin D levels. They also tested my thyroid and they told me it is not functioning properly and prescribed levothyroxine 1.0mg which I started taking 04/2022. They will perform more diagnostic testing.
received 1st dose / in Nov. or Dec. 2019 / not received 2nd dose/ due to the Covid19  Pandemic; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November or December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The patient was not sure which arm the 1st dose was administered in and the patient did not have any product details such as lot number and expiration date. Due to Covid 19 Pandemic, the patient did not receive 2nd dose of Shingrix. The patient wanted to know if he had to start over with the 1st shot due to the time frame of missing the 2nd shot. The reporter did not consent to follow up.
Vial had been left out at room air from the day before; We gave 2 doses of expired Moderna Covid-19 vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave 2 doses of expired Moderna Covid-19 vaccine.) and PRODUCT STORAGE ERROR (Vial had been left out at room air from the day before) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2022 at 10:35 AM, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave 2 doses of expired Moderna Covid-19 vaccine.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial had been left out at room air from the day before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave 2 doses of expired Moderna Covid-19 vaccine.) and PRODUCT STORAGE ERROR (Vial had been left out at room air from the day before) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided Treatment information was not provided  It was reported as following, Date the vial was initially stored in the refrigerator was 01-Mar-2022.  Date(s) and time(S) vial was first punctured was at 6pm on 03-Mar-2022. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F):16 hrs 35 min.   This case was linked to MOD-2022-502865 (Patient Link).
12hrs after my 2nd Covid Vaccine I was sleeping got up out of my bed at 4am and the room was spinning. I layed back down and had a burning sensation in my chest and my hands and feet were clammy. Several hours later at 8am same exact reaction when getting out of bed. Over the course of 3 days I remained Lightheaded.
Child presents for TB skin test reading. Mother states day after child was immunized noticed swelling and redness in AM. States child did not complain of discomfort and today arm looks better than yesterday. Today child states arm doesn't hurt. Very mild swelling, erythema noted (50mm x 50mm). Left deltoid area. Child able to move arm with no problem. Advised mother to give child aspirin free analgesic (Tylenol) and to apply cool  compress. Advised mother if notice any abnormal changes, wheezing, increased swelling and redness, difficulty breathing etc. to take child to ER ASAP.
extreme muscular fatigue/discomfort on exercise, "trigger finger" in both hands, diarrhea, sometimes explosive.  Course - persisting since mid-April - unresolving muscular fatigue, continuing bilateral joint stiffness in hands, left thumb continues to have trigger finger.
Patient reported very sharp pain in the shoulder limiting movement in the right arm, started the morning of 12/20, no obvious redness or swelling
This spontaneous report was received from a medical assistant refers to a 15 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-NOV-2016, the patient was vaccinated with an expired dose of (wistar ra 27-3) M-M-R II, expiry date: 12-NOV-2016, subcutaneous (dose, lot# and anatomical location not reported). No adverse effects reported. No further information provided. Additional information has been requested.
Information has been received from a nurse concerning a 10 year old male who on 23-FEB-2000 was vaccinated with the first dose of VARIVAX (Merck) (LOT# 632056/1449J). The nurse noted that the patient received the second dose on an unspecified date. On 14-JUL-2009 the patient developed chicken pox. The patient was seen by a nurse and no outcome was provided. No other information is available at the time of this report. Additional information has been requested.
Pt was seating on exam table. 1-2 minutes after receiving injection. I witness her fall into the wall whole body posturing, loss of consciousness. She aroused to tactile and verbal stimulus. Her color pale.
After 6 hours my arm was painful despite keeping it moving. The next day I had additional symptoms. At 2am I became aware of a slight headache. At 4am I woke up with chills and uncontrollable shaking. I put on a second set of pajamas and socks and was able to sleep 2 more hours. At 6.30am I felt very weak and nauseous. I felt aches and pain in my muscles and joints like having a cold/flu which lasted until all day and evening as did the feeling of nausea. I was fatigued all day and evening, falling asleep for 2 hours at 2.40pm and 7.11pm. I had to lay in a horizontal position most of the day to avoid vomiting. I ate very lightly and drank ginger ale and chamomile tea.
Large swollen baseball size red knot at vaccination site arrived 1 week after vacc.  Itchiness for four days and hard cellulitis under site for four days.  Took Benedryl for two days and it started to dissipate.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Feb2021 as dose 1, single (Lot number: EN6200), in left arm, on 18Mar2021 as dose 2, single (Lot number: ER2613), in left arm and on 01Oct2021 as dose 3 (booster), single (Lot number: 30155BA) at the age of 75 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Known allergies: Soy" (unspecified if ongoing); "Known allergies: walnuts" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Msg, reaction(s): "Known allergies: msg". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid course and did not test positive.
serve muscle cramping . intense head ache lasted for 2 days, chills, extremely hot. orange  colored urine.no appetite. constipation last 4 .days.
The patient developed a bright red, hard bump about the size of a hand  at the injection site approximately 1 day after receiving Moderna booster dose on 10/29/21. The bump was warm, itchy, tender, and painful to the touch. The patient came into the pharmacy on 11/1/21 and was advised to use ibuprofen, Tylenol, ice, and Benadryl. The patient used these methods but found no symptom relief. The bump persisted until 11/3/21. It had spread to her lower arm, not necessarily getting worse but not going away. The patient went to her primary care physician for further follow-up.
Positive SARS screen on 01/09/2023. No s/s at time of testing.
Systemic Inflammatory Response Syndrome, Fever, Pancytopenia, Myalgia, Tachycardia
From telephone correspondence received on 10/22/02, it was reported that a 28 year old female was vaccinated with Fluzone, lot # U0982AA, on 10/8/02. She developed a rash approximately 12 hours after vaccination. She denied any respiratory problems and was not seen by a physician. It was reported that the patient fully recovered.
Severe arm pain from shoulder to elbow, patchy redness on arm, high fever, chills, body aches, nausea and fatigue.
This spontaneous report was received from a pharmacist regarding her daughter (age unspecified). The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date, the patient's vaccine schedule is "out of compliance due to getting MMR II (dose, frequency, route, lot number were not reported) and then 2 weeks later getting VARIVAX (dose, frequency, route, lot number were not reported). There were no adverse event. There was no product quality issue (PQC) involved. Additional information is not expected.
I got sick w cough & stuffy head the same day . Kept getting sicker went to dr & was covid 19 positive
Swollen Right upper arm. Warm to touch, red. Swelling aproximately 6 " in diameter per report by mother of child.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard knot at injection site), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE PAIN (Injection site hurts) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low). On 20-Mar-2021, the patient experienced VACCINATION SITE MASS (Hard knot at injection site), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (Injection site hurts) and VACCINATION SITE SWELLING (injection site swollen). On 13-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low) had resolved. At the time of the report, VACCINATION SITE MASS (Hard knot at injection site), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (Injection site hurts) and VACCINATION SITE SWELLING (injection site swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No reported concomitant medications.  No treatment information provided.  This report refers to a case of Inappropriate route of vaccination for mRNA-1273, lot # 038A21A.Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: This report refers to a case of Inappropriate route of vaccination for mRNA-1273, lot # 038A21A.Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This is a spontaneous report from a contactable pharmacist. A 66-year-old female patient received PREVNAR13; (Lot number: J53435; Expiration date NOV2015), via an unspecified route of administration at 0.5 ml single dose on 16FEB2015. The patient medical history was not reported. Concomitant medication included ZYRTEC. It was reported that the patient received a flu shot in OCT2014. On 19FEB2015, three days after vaccination, the patient experienced an itchy rash on the arm, red arm with pain at injection site and a blotchy rash with itching. The patient also experienced a rash at the injection site reported as red, raised and itching. The patient applied hydrocortisone cream on the affected area. The pharmacist mentioned that patient wanted to know about active and inactive ingredients in this vaccine because patient was not sure whether she was allergic to something. The vaccination site redness, blotchy rash, and itching were reported as not recovered. It was reporter that the pain at the vaccination site was recovered on an unspecified date in FEB2015. The vaccination site rash was not recovered. The clinical outcome of the itchy rash on arm was unknown. Follow-up (23FEB2015): New information received from a contactable pharmacist includes: patient data (age and ethnicity), drug data (date of administration), reaction data (onset date, clinical outcome, added: blotchy rash, itching, vaccination site erythema, vaccination site pain and vaccination site rash).
Information has been received from a physician concerning a female (age unreported) with concomitant medications reported as none, allergies and pertinent medical history not specified, who on an unspecified date was vaccinated with the second dose of GARDASIL, 0.5 ml, IM.  Subsequently the patient experienced warmth and itching all over her torso.  Unspecified medical attention was sought and the reaction subsided within an hour after the vaccine was given.  No product quality complaint was involved.  Additional information is not expected.
No adverse event; 1 ml dose received for dose 2; Dose 1 received on 20-Jan-2021 and Dose 2 received on 12-Feb-2021; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (1 ml dose received for dose 2), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 20-Jan-2021 and Dose 2 received on 12-Feb-2021) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 042L20A) for COVID-19 prophylaxis.     Patient did not had any allergies.  Concurrent medical conditions included Chronic kidney disease since 22-Apr-2015, Hypertension, Pre-diabetic since 22-Apr-2015, High cholesterol, Pain and Diabetes mellitus. Concomitant products included APIXABAN (ELIQUIS) for Anticoagulant therapy, METFORMIN for Diabetes mellitus, ATORVASTATIN for High cholesterol, METOPROLOL SUCCINATE for Hypertension, IBUPROFEN for Pain.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 milliliter. On 12-Feb-2021, the patient experienced OVERDOSE (1 ml dose received for dose 2) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 20-Jan-2021 and Dose 2 received on 12-Feb-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, OVERDOSE (1 ml dose received for dose 2), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 20-Jan-2021 and Dose 2 received on 12-Feb-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for OVERDOSE (1 ml dose received for dose 2) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 received on 20-Jan-2021 and Dose 2 received on 12-Feb-2021).    No treatment drug information was provided.   This case was linked to MOD-2022-630516, MOD-2022-628730 (Patient Link).